Rapid Micro Biosystems Seeks 50%+ Gross Margins by 2028

Rapid Micro Biosystems (RPID), a developer of automated microbial testing systems, presented its growth trajectory and margin ambitions at a small-cap virtual conference, projecting revenue of approximately $34 million in 2025 and a 20% annual growth rate. The company’s recurring revenue exceeds 50% of total revenue, driven by consumables and services, with gross margins currently at 15% in Q2 but targeting 20% in Q3 and full-year 2025 guidance of about 20%. By 2028, the company aims to achieve gross margins of more than 50% at exit, reflecting a strategic push toward profitability and operational efficiency.